(Bloomberg) — A Bitcoin slide from a record high earlier this week extended to more than 10% at one point, as reduced scope for looser US monetary policy crimped speculative zeal.

Most Read from Bloomberg

• New York City’s Historic Preservation Movement Is Having a Midlife Crisis

• NYPD Car Chases Are Becoming More Frequent — and More Dangerous

• Dakar’s Air Quality Plummets as Saharan Dust Descends on Senegal

The price of the original cryptocurrency dropped as low as $95,564 on Thursday, two days after setting an all-time peak just above $108,000. The downturn weighed heavier on smaller tokens like Ether and Dogecoin.

It’s “pretty typical” to see such corrections in crypto bull markets, said Strahinja Savic, head of data and analytics at FRNT Financial.

The Federal Reserve’s hawkish pivot on Wednesday weighed on most risk assets. Bitcoin is still up almost 50% since pro-crypto Donald Trump’s victory in the US presidential election on Nov. 5.

“It looks like some year-end profit taking,” said Edward Chin of Parataxis. “There wasn’t anything fundamental that triggered the selloff.”

With fewer Fed rate cuts now expected for 2025, some investors may be choosing to reduce their exposure and take profits.

“Technically, caution is warranted in the short term,” Chris Weston, head of research at Pepperstone Group, wrote in a note. “This doesn’t mean we’re due to see a collapse in price anytime soon, but the momentum has clearly come out of the move and the buyers have lost dominance and control of the tape.”

Bitcoin changed hands at $97,836 as of 7:10 a.m. on Friday in Singapore. It has more than doubled this year, helped by a flood of inflows into US exchange-traded funds for the token.

–With assistance from Olga Kharif.

Most Read from Bloomberg Businessweek

• Office Real Estate Is Facing ‘a Year of Reckoning’ in 2025

• The Property Brothers Say Hold Off on the Big Home Renovation in 2025

• AI Giants Seek New Tactics Now That ‘Low-Hanging Fruit’ Is Gone

• Desperate Nursing Students Turn to Fixers for Their Clinical Training

©2024 Bloomberg L.P.